Tornier N.V. Q3 Loss Narrows, Backs Q4, 2014 Outlook - Quick Facts

(RTTNews) - Tornier N.V. (TRNX), which is merger with Wright Medical Group (WMGI), reported a third-quarter net loss of $5.32 million or $0.11 per share, narrower than $6.29 million or $0.13 per share in the prior-year quarter.

Excluding items, adjusted net loss for the quarter was $9.82 million or $0.20 per share, compared to $8.74 million or $0.18 per share in the year-ago quarter. On average, eight analysts polled by Thomson Reuters expected the company to report a loss of $0.20 per share for the quarter. Analysts' estimates typically exclude special items.

Net sales for the quarter increased 14.9 percent to $76.68 million from $66.75 million in the same quarter last year, while ten analysts had a consensus revenue estimate of $73.73 million.

Looking ahead to the fourth quarter, the company continues to expect revenues in a range of $83.0 million to $87.0 million and constant currency revenues in the range of $85 million to $89 million. Analysts currently expects fourth-quarter revenues of $86.93 million.

For fiscal 2014, the company also reiterates revenue guidance in a range of $334.9 million to $338.9 million and constant currency revenue forecast in the range of $335.6 million to $339.5 million. Street is currently looking for full-year 2014 revenues of $336.91 million.